0.10Open0.10Pre Close0 Volume612 Open Interest5.00Strike Price0.00Turnover2641.25%IV16.24%PremiumAug 16, 2024Expiry Date0.00Intrinsic Value100Multiplier-1DDays to Expiry0.10Extrinsic Value100Contract SizeAmericanOptions Type-0.1660Delta0.2390Gamma58.50Leverage Ratio-7.8585Theta0.0000Rho-9.71Eff Leverage0.0001Vega
Applied Therapeutics Stock Discussion
$Applied Therapeutics (APLT.US)$
The biopharmaceutical company said Thursday that the Food and Drug Administration now has a target action date of Nov. 28 for its application, compared with the previous date of Aug. 28.
The company's application is for govorestat in the treatment of Galactosemia, a rare genetic condition that makes patients unable to metab...
In a significant development for the healthcare sector and investors worldwide, Applied Therapeutics Inc. (NASDAQ:APLT), a clinical-stage biopharmaceutical company, has announced the Food and Drug Administration's acceptance and priority review of t...
No comment yet